Adam Fine

Adam Fine is the Founder and Managing Partner at Windham Capital Partners, a position held since January 2006. Additionally, Adam Fine serves as a Board Observer for ChromaCode, Inc., Upward Health, Personal Genome Diagnostics, Cureatr, Cartiva, Inc., and VytronUS, along with Board Member roles at andros and NeuSpera Medical Inc., showcasing a strong presence in the healthcare and technology sectors. Adam Fine earned an MBA in Finance from New York University and a BA in International Relations from Boston University.